Pre-Conference ISPOR Short Courses
Sunday 5 November 2000
ISPOR Short Course Educational Objectives: ISPOR Short Courses are provided to enhance the development of individuals involved in pharmacoeconomics and outcomes research or who use this research in health care decision making. Faculties, who have published in the specific discipline, present these courses. Each participant receives a course syllabus/workbook and an ISPOR Certificate of Completion. The participant will learn new methodologies and outcomes research techniques, improve skills in the specific course subject selected, and be able to apply learned skills to his/her specific work environment.
|8.00 - 12.00 PHARMACOECONOMICS|
Lieven Annemans, PhD, MMan, MSc, Director, HEDM, Meise, Belgium; Brussels Free University, Brussels, Belgium
Economic analyses (cost-effectiveness, cost-benefit, cost-utility, and cost-minimization) including the design of these studies will be presented. Discounting, decision analytic modeling, utilities and the merits of prospective versus retrospective studies will be discussed. Examples of recently published pharmacoeconomic analyses will be critiqued. This course is designed for individuals with little experience with pharmacoeconomic evaluations.
|8.00 - 12.00 DECISION ANALYSIS IN HEALTH CARE|
Mark Sculpher MSc, PhD, Senior Research Fellow, Centre for Health Economics, University of York, York, UK
The methods used in decision analysis, such as decision trees, Bayesian analysis, and spreadsheets will be discussed. Calculation of expected utilities, sensitivity analysis, assessment of patient values and inclusion of quality-of-life parameters will be discussed. This course is designed for individuals with some experience with decision analytic methods.
|8.00 - 12.00 STATISTICAL CONSIDERATIONS IN PHARMACOECONOMIC ANALYSES|
Andrew H Briggs, D.Phil, MRC Training Fellow, Health Economics Research Centre, University of Oxford
Increasingly, pharmacoeconomic evaluations are being conducted alongside clinical evaluation in a trial setting. This intermediate level course will examine statistical issues for cost-effectiveness analysis when patient level information is available on resource use and health outcome. The emphasis in the course will be on both design and analysis considerations and recent methodological developments will be reviewed. While the course necessarily involves some technical considerations, the emphasis throughout will be on the practical illustration of the methods proposed through the use of real-life examples. Participants will be expected to have a sound understanding of the principles of economic analysis and an appreciation of standard statistical methods. The course will include the following topics: Statistical analysis of cost data (cost datasets, statistical testing, handling skewness, the back transformation problem, bootstrapping); Handling missing information (complete case analysis, available case analysis, imputation methods, multiple imputation); Censoring in pharmacoeconomic analyses (Survival analysis methods for cost and cost-effectiveness); Handling uncertainty and presenting results (confidence intervals for cost-effectiveness ratios, estimation versus hypothesis testing, net-benefits and cost-effectiveness acceptability curves). This course is designed for individuals with experience with pharmacoeconomic analysis.
|8.00 - 12.00 QUALITY OF LIFE FUNDAMENTALS|
Paul Kind Mphil, Centre for Health Economics, University of York, York, UK
Conceptual, methodological, and practical methods for measuring quality of life, health status and other types of health outcomes will be presented. Theoretical frameworks, reliability, validity, responsiveness, methods of administration and issues of analysis and interpretation will be discussed. This course is designed for individuals with little experience with quality of life studies.
|8.00 - 12.00 HEALTH STATUS AND QUALITY OF LIFE MEASURES IN INTERNATIONAL CLINICAL RESEARCH|
Patrick Marquis MD, MAPI Research Institute, Lyon, France (invited)
Implementation of quality of life as an outcomes measure, development and validation of a questionnaire, cultural adaptation, and interpretation of data will be discussed. This course is designed for individuals with some experience with quality of life studies.
|Continuing Education Credit
For pharmacists (CPE): Continuing education credits for pharmacists will be provided by Butler University. Butler University designates this continuing pharmaceutical education activity for 16.5 hours (1.65 CEUs) for the European Conference and 4 hours (.4CEUs) for each pre-conference short course. Butler University is approved by the American Council of Pharmaceutical Education as a provider of continuing pharmaceutical education.
For physicians (CME): ISPOR provides documentation for Physician-designated American Medical Association (AMA) Physician's Recognition Award Category 2 continuing medical education (CME) credit. This ISPOR European Conference program complies with the AMA's definition of CME, with AMA ethical opinions on Gifts to Physicians from Industry and on Ethical Issues in CME. Up to 16.5 hours (1.65 CEUs) for the European Conference and 4 hours (.4 CEUs) for each pre-conference short course can be designated. ISPOR is not accredited by the Accreditation Council for Continuing Medical Education.
Annual European Conference